Endologix Profit Margin 2006-2018 | ELGX

Current and historical gross margin, operating margin and net profit margin for Endologix (ELGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Endologix net profit margin as of December 31, 2018 is -50.94%.
Endologix Annual Profit Margins
Endologix Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.061B $0.156B
Endologix, Inc. develops, manufactures and markets products for the treatment of coronary and vascular diseases. A leader in the emerging field of vascular brachytherapy, Endologix, has developed a unique method for the delivery of radiation to prevent restenosis following the interventional treatment of atherosclerosis.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $60.773B 20.18
Align Technology (ALGN) United States $21.893B 55.74
McKesson (MCK) United States $21.578B 8.40
AmerisourceBergen (ABC) United States $15.262B 11.07
Laboratory Of America Holdings (LH) United States $14.225B 13.08
Cooper (COO) United States $13.790B 24.06
Cardinal Health (CAH) United States $13.375B 9.01
DENTSPLY SIRONA (XRAY) United States $10.910B 24.26
Henry Schein (HSIC) United States $9.077B 14.67
West Pharmaceutical Services (WST) United States $8.232B 39.73
Merit Medical Systems (MMSI) United States $3.178B 34.20
CONMED (CNMD) United States $2.210B 35.90
Patterson (PDCO) United States $1.999B 15.79
Atrion (ATRI) United States $1.600B 46.96
STAAR Surgical (STAA) United States $1.420B 118.96
Antares Pharma (ATRS) United States $0.435B 0.00
Invacare (IVC) United States $0.229B 0.00
Lifevantage (LFVN) United States $0.158B 21.25
Pro-Dex (PDEX) United States $0.062B 28.36
Biolase (BIOL) United States $0.045B 0.00
Retractable Technologies (RVP) United States $0.021B 0.00
Milestone Scientific (MLSS) United States $0.015B 0.00